Author： Pandian R. Sumi Hemavathi K. Jayapradha R. Seenivasagam R.
Publisher： Inderscience Publishers
ISSN： 1744-5485
Source： International Journal of Bioinformatics Research and Applications, Vol.6, Iss.6, 2010-02, pp. : 556-570
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Ubiquitin ligase was an important protease in the pathogenesis of Alzheimer's Disease (AD). Currently, a handful of drugs were available and they are at best only able to offer some relief from symptoms. Cure for this disease is currently not available. Tacrine hybrids show inhibitory activities to the ubiquitin ligase. The three-dimensional quantitative structure activity relationship (3D QSAR) models and in-silico studies would be useful in developing new drug leads against Alzheimer's disease. The objective of this work involves the designing of new substances, with potential inhibitory activity over AcetylCholinesterase Enzyme (AChE), using rational drug design strategies.
Related content
Access to resources
Recommend
